Literature DB >> 10632673

Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies.

M R Ito1, S Terasaki, E Kondo, H Shiwaku, Y Fukuoka, M Nose.   

Abstract

MRL/Mp-lpr/lpr (MRL/lpr) mice develop glomerular lesions with regular variations in their histopathological manifestations, similar to those in lupus nephritis. These lesions are mainly either cell-proliferative or wire loop-like and are associated with glomerular deposits of immunoglobulins, most frequently IgG and IgM. We previously established a nephritogenic IgG3-producing hybridoma clone, B1, from an MRL/lpr mouse, which induces only a 'wire loop-like' type of glomerular lesion when injected into SCID mice. Injection of SCID mice with an anti-trinitrophenyl IgM antibody-producing hybridoma clone, Sp6, following injection of the B1 clone, however, resulted in the development of a 'cell-proliferative' type of glomerular lesion, associated with an accumulation of both antibodies in glomeruli. This accumulation occurred even though Sp6 IgM antibodies did not react with B1 IgG3 antibodies and vice versa. A mutant clone of Sp6, T/13microE/3.1, which produces antibodies deficient in C1q binding, produced a similar effect as that of the Sp6 clone, i.e. 'cell-proliferative' lesions. Again the B1 antibodies did not react with T/13microE/3. 1-IgM antibodies and vice versa. We therefore conclude that bystander IgM antibodies contribute to the remodelling of glomerular lesions in situ, following glomerular injury by the nephritogenic antibodies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632673      PMCID: PMC1905503          DOI: 10.1046/j.1365-2249.2000.01133.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Studies of serum complement in the hypocomplementaemic nephritides.

Authors:  D G Williams; D K Peters; J Fallows; A Petrie; O Kourilsky; L Morel-Maroger; J S Cameron
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

3.  Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates.

Authors:  F Ebling; B H Hahn
Journal:  Arthritis Rheum       Date:  1980-04

4.  Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

Authors:  J B Winfield; I Faiferman; D Koffler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

5.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

6.  IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group.

Authors:  T Witte; K Hartung; C Sachse; T Matthias; M Fricke; H Deicher; J R Kalden; H J Lakomek; H H Peter; R E Schmidt
Journal:  Rheumatol Int       Date:  1998       Impact factor: 2.631

7.  Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.

Authors:  M K Ho; T A Springer
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

8.  Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus.

Authors:  S Izui; P J McConahey; A N Theofilopoulos; F J Dixon
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

9.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  5 in total

1.  A human anti-dsDNA monoclonal antibody caused hyaline thrombi formation in kidneys of 'leaky' SCID mice.

Authors:  L J Mason; C T Ravirajan; D S Latchman; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 2.  Natural serum IgM maintains immunological homeostasis and prevents autoimmunity.

Authors:  Jessica J Manson; Claudia Mauri; Michael R Ehrenstein
Journal:  Springer Semin Immunopathol       Date:  2004-12-21

3.  Deficiency in activation-induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background.

Authors:  L Chen; L Guo; J Tian; B Zheng; S Han
Journal:  Clin Exp Immunol       Date:  2009-11-18       Impact factor: 4.330

4.  Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.

Authors:  Chuancang Jiang; Julie Foley; Natasha Clayton; Grace Kissling; Micheal Jokinen; Ronald Herbert; Marilyn Diaz
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

5.  Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity.

Authors:  Tomoko Ikeda; Hiroshi Fujii; Masato Nose; Yukiko Kamogawa; Tsuyoshi Shirai; Yuko Shirota; Tomonori Ishii; Hideo Harigae
Journal:  Arthritis Res Ther       Date:  2017-08-11       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.